Corbel M, Lagente V, Théret N, Germain N, Clément B, Boichot E
INSERM U 456, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes 1, 2 Avenue du Prof. Léon Bernard, Rennes, 35043, France.
Pulm Pharmacol Ther. 1999;12(3):165-71. doi: 10.1006/pupt.1999.0178.
Matrix metalloproteinases (MMPs) are particularly potent in degrading basement membrane collagen associated with lung injury in inflammatory processes. We have investigated the effects of betamethasone, cyclosporin, and nedocromil on MMP2 and MMP9 activities, on TNF-alpha and IL-10 release, as well as on the recruitment of inflammatory cells in the bronchoalveolar lavage (BAL) fluid after aerosol administration of lipopolysaccharide (LPS) in mice. When mice were pretreated with betamethasone (5 mg/kg, po), MMP2 and MMP9 activities, TNF-alpha in BAL fluids, and the enhanced neutrophil number of LPS-exposed mice were reduced, whereas the level of IL-10 was increased. Pretreatment of mice with cyclosporin (10 mg/kg, po) did not significantly reduce MMP activities, but cyclosporin inhibited neutrophil recruitment, inhibited increase TNF- alpha and inhibited IL-10 decrease. Nedocromil sodium (30 mg/kg, ip) had no influence on the LPS-induced MMP activities, on neutrophil recruitment, or on IL-10 level, but this drug elicited a significant inhibition of TNF- alpha level. These results showed that treatment with the antiinflammatory drugs cyclosporin and nedocromil sodium did not lead to reduction of MMP release. However, since betamethasone reduced the LPS-induced pulmonary inflammation and production of MMPs, these results suggest that corticosteroids may decrease tissue remodelling associated with acute lung injury.
基质金属蛋白酶(MMPs)在炎症过程中降解与肺损伤相关的基底膜胶原蛋白方面具有特别强的作用。我们研究了倍他米松、环孢素和奈多罗米对MMP2和MMP9活性、TNF-α和IL-10释放的影响,以及在小鼠雾化吸入脂多糖(LPS)后对支气管肺泡灌洗(BAL)液中炎症细胞募集的影响。当小鼠用倍他米松(5 mg/kg,口服)预处理时,MMP2和MMP9活性、BAL液中的TNF-α以及LPS暴露小鼠中性粒细胞数量的增加均减少,而IL-10水平升高。用环孢素(10 mg/kg,口服)预处理小鼠并未显著降低MMP活性,但环孢素抑制中性粒细胞募集,抑制TNF-α增加并抑制IL-10降低。奈多罗米钠(30 mg/kg,腹腔注射)对LPS诱导的MMP活性、中性粒细胞募集或IL-10水平没有影响,但该药物可显著抑制TNF-α水平。这些结果表明,用抗炎药物环孢素和奈多罗米钠治疗不会导致MMP释放减少。然而,由于倍他米松减少了LPS诱导的肺部炎症和MMPs的产生,这些结果表明皮质类固醇可能会减少与急性肺损伤相关的组织重塑。